TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative ...

NEW YORK (AP) — It wasn’t until his junior year of college that civil rights attorney Damario Solomon-Simmons learned about a devastating massacre that took place in his hometown of Tulsa, Oklahoma.

Jeffrey Tanenhaus’s architecture walking tour in Tulsa, Okla., is only a mile long, but it takes two hours. He stops frequently to point out neoclassical and art deco flourishes. You’d never know he ...

Israel's Prime Minister Benjamin Netanyahu speaks during a ceremony commemorating Israel's Remembrance Day for fallen soldiers, or Yom HaZikaron, at the Military Cemetery on Mount Herzl in Jerusalem ...

Israeli Prime Minister Benjamin Netanyahu was treated for early-stage prostate cancer 18 months ago, he revealed Friday, saying he delayed making the news public so Iran would not use it as ...

TEL AVIV — Israeli Prime Minister Benjamin Netanyahu said Friday that he had been diagnosed with and treated for early-stage prostate cancer but delayed revealing his condition for two months to avoid ...

Israeli Prime Minister Benjamin Netanyahu quietly underwent treatment for prostate cancer, he said Friday, as he publicized the results of his annual medical examination. Netanyahu, 76, said he ...

The Israeli leader had surgery in 2024 for an enlarged prostate. More recently, follow-up care detected a tumor, his office disclosed on Friday. By David M. Halbfinger Reporting from Jerusalem Prime ...

MONDAY, April 20, 2026 (HealthDay News) -- Magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) shows better initial perioperative outcomes than robotic prostatectomy (RP) ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives when treated with ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with ...

TORONTO (April 13, 2026)—A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives ...